Charles River Laboratories (NYSE:CRL)

CAPS Rating: 4 out of 5

The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.

Recs

0
Player Avatar yunak (< 20) Submitted: 8/2/2008 2:36:24 AM : Outperform Start Price: $66.25 CRL Score: -57.45

I like this one.

Featured Broker Partners


Advertisement